The SARS-CoV-2 test scale-up in the USA: an analysis of the number of tests produced and used over time and their modelled impact on the COVID-19 pandemic
Authors:
Open Access
- 5 January 2025
- journal article
- research article
- Published by Elsevier in The Lancet Public Health
- Vol. 10 (1) , e47-e57
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Centers for Disease Control and Prevention
- U.S. Department of Health and Human Services
- U.S. Food and Drug Administration
This publication has 31 references indexed in Scilit:
- Proposal for a national diagnostics action plan for the United StatesHealth Policy OPEN, 2023
- Covid-19 Surveillance Testing and Resident Outcomes in Nursing HomesNew England Journal of Medicine, 2023
- Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, EnglandEpidemiology and Infection, 2023
- Macroeconomic consequences of the COVID-19 pandemicEconomic Modelling, 2022
- Rapid Diagnostic Testing for SARS-CoV-2New England Journal of Medicine, 2022
- Diagnostics for COVID-19: moving from pandemic response to controlThe Lancet, 2021
- An Agent-Based Covid-19 Simulator: Extending Covasim to the Polish ContextProcedia Computer Science, 2021
- The impact of COVID-19 vaccination delay: A data-driven modeling analysis for Chicago and New York CityVaccine, 2021
- Controlling COVID-19 via test-trace-quarantineNature Communications, 2021
- The COVID-19 Pandemic and the $16 Trillion VirusJAMA, 2020